Literature DB >> 11481439

Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme.

T Sandalova1, L Zhong, Y Lindqvist, A Holmgren, G Schneider.   

Abstract

Thioredoxin reductases (TrxRs) from mammalian cells contain an essential selenocysteine residue in the conserved C-terminal sequence Gly-Cys-SeCys-Gly forming a selenenylsulfide in the oxidized enzyme. Reduction by NADPH generates a selenolthiol, which is the active site in reduction of Trx. The three-dimensional structure of the SeCys498Cys mutant of rat TrxR in complex with NADP(+) has been determined to 3.0-A resolution by x-ray crystallography. The overall structure is similar to that of glutathione reductase (GR), including conserved amino acid residues binding the cofactors FAD and NADPH. Surprisingly, all residues directly interacting with the substrate glutathione disulfide in GR are conserved despite the failure of glutathione disulfide to act as a substrate for TrxR. The 16-residue C-terminal tail, which is unique to mammalian TrxR, folds in such a way that it can approach the active site disulfide of the other subunit in the dimer. A model of the complex of TrxR with Trx suggests that electron transfer from NADPH to the disulfide of the substrate is possible without large conformational changes. The C-terminal extension typical of mammalian TrxRs has two functions: (i) it extends the electron transport chain from the catalytic disulfide to the enzyme surface, where it can react with Trx, and (ii) it prevents the enzyme from acting as a GR by blocking the redox-active disulfide. Our results suggest that mammalian TrxR evolved from the GR scaffold rather than from its prokaryotic counterpart. This evolutionary switch renders cell growth dependent on selenium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481439      PMCID: PMC55487          DOI: 10.1073/pnas.171178698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Purification, crystallization and preliminary crystallographic data for rat cytosolic selenocysteine 498 to cysteine mutant thioredoxin reductase.

Authors:  L Zhong; K Persson; T Sandalova; G Schneider; A Holmgren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-09

2.  A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase.

Authors:  S Gromer; J Wissing; D Behne; K Ashman; R H Schirmer; L Flohé; K Becker
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  Preparation and assay of mammalian thioredoxin and thioredoxin reductase.

Authors:  E S Arnér; L Zhong; A Holmgren
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

4.  Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence.

Authors:  L Zhong; E S Arnér; A Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 5.  Thioredoxin.

Authors:  A Holmgren
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

6.  Convergent evolution of similar function in two structurally divergent enzymes.

Authors:  J Kuriyan; T S Krishna; L Wong; B Guenther; A Pahler; C H Williams; P Model
Journal:  Nature       Date:  1991-07-11       Impact factor: 49.962

7.  Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution.

Authors:  P A Karplus; G E Schulz
Journal:  J Mol Biol       Date:  1989-11-05       Impact factor: 5.469

Review 8.  Thioredoxin reductase two modes of catalysis have evolved.

Authors:  C H Williams; L D Arscott; S Müller; B W Lennon; M L Ludwig; P F Wang; D M Veine; K Becker; R H Schirmer
Journal:  Eur J Biochem       Date:  2000-10

9.  Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue.

Authors:  L Zhong; E S Arnér; J Ljung; F Aslund; A Holmgren
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

10.  Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols.

Authors:  M Björnstedt; M Hamberg; S Kumar; J Xue; A Holmgren
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

View more
  66 in total

1.  Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling.

Authors:  Chao Yan; David Siegel; Jeffery Newsome; Aurelie Chilloux; Christopher J Moody; David Ross
Journal:  Mol Pharmacol       Date:  2011-12-06       Impact factor: 4.436

2.  Non-animal origin of animal thioredoxin reductases: implications for selenocysteine evolution and evolution of protein function through carboxy-terminal extensions.

Authors:  Sergey V Novoselov; Vadim N Gladyshev
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

3.  Selective targeting of selenocysteine in thioredoxin reductase by the half mustard 2-chloroethyl ethyl sulfide in lung epithelial cells.

Authors:  Yi-Hua Jan; Diane E Heck; Joshua P Gray; Haiyan Zheng; Robert P Casillas; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

4.  Crystal structure of the human thioredoxin reductase-thioredoxin complex.

Authors:  Karin Fritz-Wolf; Sebastian Kehr; Michaela Stumpf; Stefan Rahlfs; Katja Becker
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

Review 5.  The effects of acrolein on the thioredoxin system: implications for redox-sensitive signaling.

Authors:  Charles R Myers; Judith M Myers; Timothy D Kufahl; Rachel Forbes; Adam Szadkowski
Journal:  Mol Nutr Food Res       Date:  2011-08-03       Impact factor: 5.914

Review 6.  Selenoproteins: molecular pathways and physiological roles.

Authors:  Vyacheslav M Labunskyy; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

7.  Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide.

Authors:  Venkat R Pannala; Ranjan K Dash
Journal:  Free Radic Biol Med       Date:  2014-10-29       Impact factor: 7.376

8.  Oxadiazole 2-oxides are toxic to the human hookworm, Ancylostoma ceylanicum, however glutathione reductase is not the primary target.

Authors:  R S Treger; A G Cook; G Rai; D J Maloney; A Simeonov; A Jadhav; C J Thomas; D L Williams; M Cappello; J J Vermeire
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-05-18       Impact factor: 4.077

9.  Curcuminoids as inhibitors of thioredoxin reductase: a receptor based pharmacophore study with distance mapping of the active site.

Authors:  Durg Vijay Singh; Krishna Misra
Journal:  Bioinformation       Date:  2009-10-24

10.  Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes.

Authors:  Elena S Suvorova; Olivier Lucas; Carla M Weisend; Maryclare F Rollins; Gary F Merrill; Mario R Capecchi; Edward E Schmidt
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.